{"author_id": "963495628545327104", "id": "1530124686151098370", "created_at": "2022-05-27T09:52:08.000Z", "text": "$ABBV NEW ARTICLE : ABBV SHAREHOLDER ALERT: Jakubowitz Law Reminds AbbVie Shareholders of a Lead Plaintiff Deadline of June 6, 2022 https://t.co/4iCdBr9vYX Get all the latest $ABBV related news here : https://t.co/QFefYxn1ad https://t.co/DEsCHeH5Rl"}
{"text": "Bull Forecasts\nMay 27, 2022 08:06:00 PDT\n\ud83d\udc02\ud83d\udc02\ud83d\udc02\ud83d\udc02\ud83d\udc02\nticker : log change intraday\n$LAZR : 1.12\n$ABBV : -0.72\n$SPY : 0.77\n$COTY : 1.38\n$USO : 0.17\n$ASAN : 4.18\n$ACN : 2.76\n$BROS : 7.51\n$COST : 1.84\n$NKLA : 3.07", "author_id": "1396180686847938560", "id": "1530204671268139008", "created_at": "2022-05-27T15:09:58.000Z"}
{"author_id": "1488699517914345474", "id": "1530087905024040960", "created_at": "2022-05-27T07:25:58.000Z", "text": "$ABBV - https://t.co/3eL3mpJ8MG - The Lancet Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Upadacitinib (RINVOQ\u00ae) in Ulcerative Colitis"}
{"text": "RT @BrandonVanZee: Here's the intro of today's #MarketOutlook video from @MarketScholars \n\nWatch the full video for free here:\n\nhttps://t.c\u2026", "id": "1530328339751194624", "author_id": "851941419933507584", "created_at": "2022-05-27T23:21:22.000Z"}
{"text": "$ABBV All that you need to know' Shorts haven't covered a single share..... https://t.co/Z5W7IANn7Q", "id": "1530243155362140160", "author_id": "1520597618573049857", "created_at": "2022-05-27T17:42:53.000Z"}
